IMMUNOPRECISE ANTIBODIES LTD

NASDAQ: IPA (ImmunoPrecise Antibodies Ltd.)

Last update: 1 hour ago

1.76

-0.45 (-20.36%)

Previous Close 2.21
Open 2.26
Volume 11,230,600
Avg. Volume (3M) 1,906,304
Market Cap 95,538,984
Price / Sales 3.32
Price / Book 5.98
52 Weeks Range
0.270 (-84%) — 3.25 (84%)
Earnings Date 10 Dec 2025
Profit Margin -194.79%
Operating Margin (TTM) -53.47%
Diluted EPS (TTM) -1.22
Quarterly Revenue Growth (YOY) -1.10%
Total Debt/Equity (MRQ) 51.46%
Current Ratio (MRQ) 2.32
Operating Cash Flow (TTM) -7.91 M
Levered Free Cash Flow (TTM) -3.63 M
Return on Assets (TTM) -14.88%
Return on Equity (TTM) -124.75%

Market Trend

Short Term Medium Term
Industry Biotechnology (US) Mixed Bearish
Biotechnology (Global) Mixed Bearish
Stock ImmunoPrecise Antibodies Ltd. Bearish Bearish

AIStockmoo Score

-1.1
Analyst Consensus -2.0
Insider Activity NA
Price Volatility -4.5
Technical Moving Averages 2.5
Technical Oscillators -0.5
Average -1.13

Similar Stocks

Stock Market Cap DY P/E (TTM) P/B
IPA 96 M - - 5.98
MRNA 9 B - - 0.970
CGON 3 B - - 3.79
HRMY 2 B - 10.45 2.68
MESO 2 B - - 3.18
ABCL 1 B - - 1.33

ImmunoPrecise Antibodies Ltd is a techbio company that leverages multi-omics modeling and complex artificial intelligence through a series of proprietary and patented technologies. The Company owns an integrated end-to-end suite of capabilities to support the development of therapeutic antibodies and are known for solving very complex industry challenges. IPA has several subsidiaries in North America and Europe.

Sector Healthcare
Industry Biotechnology
Investment Style Small Value
% Held by Insiders 5.21%
% Held by Institutions 8.65%

No data within this time range.

No data within this time range.

The support, resistance and trendline levels presented has been generated by an artificial intelligence (AI) model and should be interpreted with caution.

Portfolio

AI Template

Your price alert

Risk Profile

| | | | |
Conservative
Moderate Conservative
Moderate
Moderate Aggressive
Aggressive
Margin of Safety (EP)
Partial Profit (TP1)
Target Profit (TP2)
Maximum Loss (SL)

Disclaimer: The above is for illustrative purposes only and is NOT investment advice. Seek advice from a qualified financial professional.

Entry Price (EP)

Take Profit 1 (TP1)

Take Profit 2 (TP2)

Stop Loss (SL)

52W Range
 
52WL
 
52WH
SL
EP
TP1
TP2

All alert prices are within 52 weeks price range

Realized Profit -
Unrealized Profit -
Dividend Received 2025 -
Total Profit -
Avg. Return -
Quantity (Buy) -
Avg. Price (Buy) -
Quantity (Sold) -
Avg. Price (Sold) -
No stocks matching your criteria